go back

Rhode Island rates for HCPCS Q2041

Axicabtagene ciloleucel, up to 200 million autologous anti-CD19 CAR positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $537,032 · 10th–90th $537,032–$1,047,1290%50%90th$537,032Professionalmedian $537,032 · 10th–90th $537,032–$616,5950%50%90th$537,032$1.0$10.0$100.0$1.0K$10.0K$100.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,047,128.55 / $1,047,128.55 / $1,047,128.55
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $616,595.00
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $562,341.33
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $537,031.80
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $645,654.23
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $537,031.80
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$31,622.78 / $501,187.23 / $537,031.80